Company Search:
Advanced Search
Sponsored Links
Shandong Lukang Pharmaceutical Company Snapshot
Shandong Lukang Pharmaceutical operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Lukang Pharmaceutical with three other companies in this sector in China: Shenzhen Hepalink Pharmaceutical Company Limited (2016 sales of 2.26 billion Chinese Renmimbi [US$355.93 million] of which 100% was Pharmaceutical Manufacturing), Zhejiang Jianfeng Group Company Limited (2.38 billion Chinese Renmimbi [US$374.72 million] of which 45% was Pharmaceutical), and ChangChun High New Technology Industries (2.87 billion Chinese Renmimbi [US$452.72 million] of which 81% was Medication).

Sales Analysis. During the year ended December of 2016, sales at Shandong Lukang Pharmaceutical were 2.51 billion Chinese Renmimbi (US$394.65 million). This is an increase of 4.0% versus 2015, when the company's sales were 2.41 billion Chinese Renmimbi. This was the third consecutive year of growth at Shandong Lukang Pharmaceutical. The sales level in 2016 was fairly close to the level five years ago: in 2011, Shandong Lukang Pharmaceutical had sales of 2.33 billion Chinese Renmimbi. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 61.8% in 2016, from 56.60 million Chinese Renmimbi to 91.61 million Chinese Renmimbi. Shandong Lukang Pharmaceutical also saw significant increases in sales in Veterinary Antibiotic (up 13.6% to 687.92 million Chinese Renmimbi) and Other Operation (up 9.3% to 36.25 million Chinese Renmimbi) . Not all segments of Shandong Lukang Pharmaceutical experienced an increase in sales in 2016: sales of Human Antibiotic fell 1.5% to 1.69 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shandong Lukang Pharmaceutical
  Stock Performance Chart for Shandong Lukang Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2018): 10.24
(Figures in Chinese Renmimbi)
1 Week 13.5%   13 Weeks 23.8%  
4 Weeks 35.4%   52 Weeks -2.1%  
Shandong Lukang Pharmaceutical Key Data:
  Ticker: 600789 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 2,505,231,741
(Year Ending Jan 2017).
Employees: 5,938
  Currency: Chinese Renmimbi Market Cap: 5,955,332,864
  Fiscal Yr Ends: December Shares Outstanding: 581,575,475
  Share Type: A Gu Closely Held Shares: 187,587,115
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.